Home / Weight Loss / Compare
Compounded vs. brand-name GLP-1s: what’s the difference?
Quick answer
Brand-name GLP-1s like Wegovy® and Zepbound® are FDA-approved and made by Novo Nordisk and Eli Lilly.
Compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies for individual patients and are not FDA-approved.
At Surna, compounded GLP-1s start at $109/mo. Brand-name medications are priced by dose, starting at $235/mo, plus a $49/mo care fee.
Updated · Sources below
Side by side
| Feature | Brand-name GLP-1s | Compounded GLP-1s |
|---|---|---|
| FDA-approved | Yes | No |
| Made by | Novo Nordisk, Eli Lilly | A state-licensed compounding pharmacy, named on your label |
| Studied in large clinical trials | Yes | The compounded products themselves have not been |
| Forms at Surna | Pens and the Wegovy® pill | Weekly injection or daily dissolving tablet |
| Insurance | Sometimes covered | Self-pay |
| Surna starting price | $235/mo | $109/mo |
Which is right for you?
Your provider makes the final call based on your health history.
Choose Brand-name GLP-1s if
- You want an FDA-approved medication
- Your insurance may cover it
- You prefer a prefilled pen or an FDA-approved pill
Choose Compounded GLP-1s if
- You’re paying out of pocket and want a lower price
- You want a daily dissolving tablet
- You’re comfortable with a medication compounded by a licensed pharmacy
What “compounded” means
Compounding is when a licensed pharmacy prepares a medication for an individual patient’s prescription. Compounded drugs are not FDA-approved, which means the FDA does not review their safety, effectiveness, or quality before they’re dispensed.
Regulation is changing
After the FDA declared the national shortages of semaglutide and tirzepatide resolved, the rules for compounding these medications tightened, and regulators have warned companies that market compounded GLP-1s as the same as brand-name drugs. At Surna, compounded GLP-1s are dispensed by state-licensed pharmacies that are named on your label.
Safety
Compounded and brand-name GLP-1s have the same class of side effects. The FDA has received reports of dosing errors with compounded injectable GLP-1s, often from confusion about units or syringe measurements, so follow your label and your care team’s instructions exactly.
Cost at Surna
Compounded semaglutide starts at $109/mo and compounded tirzepatide at $139/mo. Brand-name medications are priced by dose, plus a $49/mo care fee, and plan discounts don’t apply to them.
Questions, answered
Is compounded semaglutide the same as Wegovy®?
No. Wegovy® is FDA-approved. Compounded semaglutide is prepared by a state-licensed pharmacy, is not FDA-approved, and is not the same product.
Is compounded semaglutide legal?
Licensed pharmacies can compound medications for individual patients under federal and state compounding rules. Those rules have changed over time, so availability can change.
Why do brand-name GLP-1s cost more?
Brand-name medications are priced by the manufacturer. At Surna you pay one monthly price that includes the medication and your provider care.
Does insurance cover compounded GLP-1s?
Generally no. Compounded GLP-1s are self-pay. Some insurance plans cover brand-name weight management medications.
Sources
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Source
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. Source
This page is general information, not medical advice. A licensed provider will determine whether treatment is appropriate for you. Individual results vary. Wegovy®, Ozempic®, and Rybelsus® are registered trademarks of Novo Nordisk; Zepbound® and Mounjaro® of Eli Lilly and Company; Viagra® of Viatris; Cialis® of Eli Lilly and Company. Surna Health is not affiliated with these companies.
Not sure which? Let a provider help.
Answer a few questions and a licensed provider will recommend the option that fits you.
Start your assessmentImportant safety information
GLP-1 medications may cause thyroid C-cell tumors, including medullary thyroid carcinoma, based on studies in rodents; it is unknown whether this happens in people. Do not use if you or a family member has had medullary thyroid carcinoma or if you have MEN 2. Other serious risks include pancreatitis, gallbladder problems, low blood sugar when used with other diabetes medicines, kidney problems from dehydration, serious allergic reactions, increased heart rate, and changes in vision for people with diabetic retinopathy. Watch for changes in mood or thoughts of self-harm and tell your provider right away.
This is not a complete list of risks. Talk with your provider and read the full prescribing information or medication guide. Full safety information.